Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Houthi attack on Saudi airport kills 12, over 300 wounded, authorities say
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Coverage News on Teva's (TEVA) Migraine Drug is a 'Clear Negative' - Wells Fargo
October 17, 2018 11:06 AM EDTWells Fargo analyst David Maris weighed in on Teva Pharma (NYSE: TEVA) after Express Scripts announced it is not going to cover Teva's new migraine drug.
Maris called the news a "clear negative" for Teva as the new drug is its... More



